In re Incretin-Based Therapies Products Liability Litigation

*1111ORDER GRANTING DEFENDANTS’ MOTION FOR SUMMARY JUDGMENT AND DENYING PLAINTIFFS’ CROSS-MOTION FOR SUMMARY JUDGMENT

Hon. Anthony J. Battaglia, United States District Judge

I. INTRODUCTION

Through the ■ enactment of the Federal Food, Drug, 'and Cosmetics Act, *111221 U.S.C. § 301 et seq., Congress, delegated authority to the Food and Drug Administration (“FDA”) to regulate pharmaceutical manufacturers and their products. With subsequent amendments, Congress enlarged this authority, charging the FDA with the power to protect the public health, and to assure the safety, effectiveness, and reliability…